Department Of Neurology
Investigator
Thomas Brannagan, MD
Email
tb2325@cumc.columbia.edu

Dr. Brannagan is the director of the Peripheral Neuropathy Center at Columbia University Medical Center. He graduated from the University of Virginia and also received his medical degree from the University of Virginia in Charlottesville. He completed his Neurology residency training at the Neurological Institute of Columbia Presbyterian Medical Center between 1991 and 1994. He subsequently did a Neuromuscular EMG fellowship at Columbia, followed by a Neuroimmunology fellowship in the laboratory of Dr. Norman Latov. Prior to returning to Columbia, Dr. Brannagan was the director of the Diabetic Neuropathy Research center at Cornell University in New York City and was co-director of the EMG laboratory at MCP-Hahnemann University in Philadelphia.

He is a member of the American Academy of Neurology, the American Neurological Association, as well as the American Association of Electrodiagnostic Medicine. He is also a member of the Neuropathy Association and the Peripheral Nerve Society. 


Clinical Studies Managed By This Investigator:
Condition Study Title
Neuropathy [ CLOSED ] Study of patients with neuropathy using study drug, ISIS TTR Rx
Neuropathy [ CLOSED ] Study for treating patients with neuropathy using study drug fingolimod
Neuropathy [ CLOSED ] Study for patients with Amyloidsis (TTR) using an investigational drug, ALN-TTR02 for treatment
Neuropathy [ CLOSED ] Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) and Treatment with Subcutaneous Immunoglobulin
Autoimmune Disorders [ CLOSED ] A study for patients with Lambert-Eaton Myasthenic Syndrome (LEMS) using study drug Amifampridine Phosphate
Neuromuscular [ CLOSED ] Efficacy and Safety of IGIV-C in Corticosteroid Dependent Patients With Generalized Myasthenia Gravis
Neuromuscular [ CLOSED ] A Study for Patients With Generalized Myasthenia Gravis Using Intravenous Human Immunoglobulin Concentrate, IGIV-C.
Neuropathy [ CLOSED ] A Study for Patients with Neuropathy Associated Pain to Compare study drugs Nortriptyline, Duloxetine, Pregabalin and Mexiletine
Neuropathy [ CLOSED ] A Study for Charcot-Marie-Tooth type 1A Patients to Compare 2 doses of PXT3003 vs. a Placebo
Neuropathy [ CLOSED ] A Study to Assess the Clinical and Biological Predictors of Disease Course in Patients with Guillain-Barre Syndrome
Neuropathy [ CLOSED ] A Study to Assess the Treatment-Related Fluctuations in CIDP Patients Using Daily Grip Strength Measurements
Neuropathy [ CLOSED ] Phase 3 Gene Therapy for Painful Diabetic Neuropathy
Neuromuscular [ CLOSED ] A Study to Evaluate the Efficacy and Safety of VX-150 in Treating Subjects With Pain Caused by Small Fiber Neuropathy
Cancer [ CLOSED ] Prospective Study of Chemotherapy-Induced Peripheral Neuropathy
Neuropathy [ CLOSED ] Top-CSPN Study
Neuromuscular [ CLOSED ] Flex CMT Muscle Cramps Study
Neurological Disorders [ CLOSED ] RESTORE: A Study of Patients with symptomatic neurogenic orthostatic hypotension (NOH)
Neurological Disorders [ CLOSED ] Study of Study Drug (ACE-083) in Patients with Carcot-Marie-Tooth Disease Types 1 and X
Amyloidosis [ CLOSED ] HELIOS-A: A Study of Vutrisiran (ALN-TTRSC02) in Patients With Hereditary Transthyretin Amyloidosis (hATTR Amyloidosis)
Neuropathy [ CLOSED ] A Study of Rozanolixizumab in Subjects With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (MyCIDPchoice)
Amyloidosis [ CLOSED ] Study of ION-682884 (SC) in patients with TTR Amyloidosis Polyneuropathy
Neuromuscular Study of Efgartigimod PH20 in Patients Age 18 and Older with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Neurological Disorders [ CLOSED ] A Study to Test a New Drug (PXT3003-06) in Patients with Charcot-Marie-Tooth Type 1A (CMT1A)
Neurological Disorders Study of SAR445088 in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Neurological Disorders Efficacy and Safety of Nipocalimab in Patients with Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)